Zhengye Biotechnology(ZYBT.US)

Company Encyclopedia
View More
name
Zhengye Biotechnology
ZYBT.US
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. Its veterinary vaccines include monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. The company also develops vaccines for household animals.
4.807 T
ZYBT.USMarket value -Rank by Market Cap -/-

Financial Score

11/01/2026 Update
D
PharmaceuticalsIndustry
Industry Ranking149/185
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-6.67%D
    • Profit Margin-12.60%D
    • Gross Margin31.10%C
  • Growth ScoreD
    • Revenue YoY-18.57%E
    • Net Profit YoY-195.95%E
    • Total Assets YoY4.87%C
    • Net Assets YoY5.76%B
  • Cash ScoreE
    • Cash Flow Margin-793.76%E
    • OCF YoY-18.57%E
  • Operating ScoreD
    • Turnover0.31D
  • Debt ScoreB
    • Gearing Ratio27.65%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    U.S. stock market update: Zhengye Biotechnology up 26.03%

    Zhengye Biotechnology rose 26.03%; Pfizer rose 4.39%, with a transaction volume of USD 886 million; Eli Lilly rose 0.78%, with a transaction volume of USD 457 million; Johnson & Johnson rose 1.15%, with a transaction volume of USD 348 million; Novartis rose 1.71%, with a market value of USD 244.3 billion

    Tracking Unusual Activity·
    US
    ZYBT
    +0.88%
    Tracking Unusual Activity·
    US
    ZYBT
    +0.88%

    U.S. stock market update: Zhengye Biotechnology up 13.59%

    Zhengye Biotechnology rose 13.59%; Eli Lilly fell 0.09%, with a trading volume of USD 1.344 billion; Novo Nordisk fell 0.52%, with a trading volume of USD 796 million; Johnson & Johnson rose 0.77%, with a trading volume of USD 709 million; Novartis rose 0.23%, with a market capitalization of USD 239.9 billion

    Tracking Unusual Activity·
    US
    ZYBT
    +0.88%
    Tracking Unusual Activity·
    US
    ZYBT
    +0.88%

    Pre-market hot trades in US stocks: Zhengye Biotechnology up 12.07% in pre-market; Platinum Analytics Cayman - CL down 7.80% in pre-market

    Zhengye Biotechnology pre-market up 12.07%; Platinum Analytics Cayman - CL pre-market down 7.80%; PepGen pre-market up 124.44%; WORK Medical Tech pre-market up 48.44%; OFA pre-market up 44.36%

    Tracking Unusual Activity·
    US
    ZYBT
    +0.88%
    US
    PLTS
    0.00%
    Tracking Unusual Activity·
    US
    ZYBT
    +0.88%
    US
    PLTS
    0.00%

    Freeport-McMoRan, Harmony Biosciences, Cohu, And Other Big Stocks Moving Lower On Wednesday

    U.S. stocks fell on Wednesday, with the Dow Jones dropping over 150 points. Freeport-McMoRan Inc. shares plummeted 16.4% to $37.94 after issuing disappointing third-quarter sales guidance and reporting fatalities from a mine incident. Other notable declines included Zhengye Biotechnology (-28.2%), Harmony Biosciences (-14.6%), and Cohu, Inc. (-12.7%). Harmony's stock fell after its clinical trial for ZYN002 failed to meet primary endpoints, prompting a price target cut by Needham. Overall, several stocks experienced significant losses during the trading session.

    Benzinga·
    US
    ZYBT
    +0.88%
    Benzinga·
    US
    ZYBT
    +0.88%

    U.S. stock market update: Zhengye Biotechnology down 15.88%

    Zhengye Biotechnology fell 15.88%; Eli Lilly fell 0.53%, with a transaction volume of USD 517 million; Pfizer fell 0.02%, with a transaction volume of USD 304 million; Merck rose 0.61%, with a transaction volume of USD 268 million; Johnson & Johnson fell 0.10%, with a market value of USD 424.9 billion

    Tracking Unusual Activity·
    US
    ZYBT
    +0.88%
    Tracking Unusual Activity·
    US
    ZYBT
    +0.88%
    © 2026 Longbridge｜Disclaimer